Catalyst Private Wealth »

Rapport Therapeutics shares owned by Catalyst Private Wealth

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Catalyst Private Wealth from 13F filings

Historical chart of Catalyst Private Wealth investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Catalyst Private Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Catalyst Private Wealth

Quarter filed Position value Share count Share price at filing
2025-12-31 $303k 10k 30.34
2025-09-30 $297k 10k 29.70
2025-06-30 $114k 10k 11.37
2025-03-31 $100k 10k 10.03

More positions owned by Catalyst Private Wealth

Atlassian Corporation Cl A (TEAM)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ssga Active Tr Spdr Bridgewater (ALLW)
Affirm Hldgs Com Cl A (AFRM)
Ishares Tr Core Msci Total (IXUS)
Doordash Cl A (DASH)
Meta Platforms Cl A (META)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Series Trust State Street Spd (SPYM)
Samsara Com Cl A (IOT)
Ishares Tr Msci Acwi Etf (ACWI)

View all positions for Catalyst Private Wealth

Top funds holding Rapport Therapeutics

TRV GP V
FMR
Arch Venture Corp
Capital Research and Management Company - Division 3
Cormorant Asset Management
Goldman Sachs Group
BlackRock
Sofinnova Ventures
Vanguard Group
Johnson & Johnson
Baker Bros. Advisors
Vestal Point Capital
Polar Capital Holdings
Trv Gp Vi
Ubs Global Asset Management Americas

View all funds holding Rapport Therapeutics